Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Prehospital lactate improves prediction of the need for immediate interventions for hemorrhage after trauma.

Fukuma H, Nakada TA, Shimada T, Shimazui T, Aizimu T, Nakao S, Watanabe H, Mizushima Y, Matsuoka T.

Sci Rep. 2019 Sep 24;9(1):13755. doi: 10.1038/s41598-019-50253-6.

2.

Association between serum levels of interleukin-6 on ICU admission and subsequent outcomes in critically ill patients with acute kidney injury.

Shimazui T, Nakada TA, Tateishi Y, Oshima T, Aizimu T, Oda S.

BMC Nephrol. 2019 Mar 1;20(1):74. doi: 10.1186/s12882-019-1265-6.

3.

Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer.

Koie T, Ohyama C, Makiyama K, Shimazui T, Miyagawa T, Mizutani K, Tsuchiya T, Kato T, Nakane K.

Int J Urol. 2019 Mar;26(3):334-340. doi: 10.1111/iju.13900. Epub 2019 Jan 28. Review.

PMID:
30690817
4.

Systemic transduction of p16INK4a antitumor peptide inhibits lung metastasis of the MBT-2 bladder tumor cell line in mice.

Shimazui T, Yoshikawa K, Ishitsuka R, Kojima T, Kandori S, Yoshino T, Miyazaki J, Uchida K, Nishiyama H.

Oncol Lett. 2019 Jan;17(1):1203-1210. doi: 10.3892/ol.2018.9655. Epub 2018 Nov 1.

5.

Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin.

Kandori S, Kojima T, Matsuoka T, Yoshino T, Sugiyama A, Nakamura E, Shimazui T, Funakoshi Y, Kanaho Y, Nishiyama H.

Cancer Sci. 2018 Jun;109(6):1865-1875. doi: 10.1111/cas.13609. Epub 2018 May 25.

6.

Endogenous reference RNAs for microRNA quantitation in formalin-fixed, paraffin-embedded lymph node tissue.

Inada K, Okoshi Y, Cho-Isoda Y, Ishiguro S, Suzuki H, Oki A, Tamaki Y, Shimazui T, Saito H, Hori M, Iijima T, Kojima H.

Sci Rep. 2018 Apr 12;8(1):5918. doi: 10.1038/s41598-018-24338-7.

7.

Influence of autophagy on acute kidney injury in a murine cecal ligation and puncture sepsis model.

Sunahara S, Watanabe E, Hatano M, Swanson PE, Oami T, Fujimura L, Teratake Y, Shimazui T, Lee C, Oda S.

Sci Rep. 2018 Jan 18;8(1):1050. doi: 10.1038/s41598-018-19350-w.

8.

Development of Noninvasive in Vivo Approach to Assess Vascular Permeability in Inflammation Using Fluorescence Imaging.

Shimazui T, Nakada TA, Fujimura L, Sakamoto A, Hatano M, Oda S.

Shock. 2018 Dec;50(6):729-734. doi: 10.1097/SHK.0000000000001075.

PMID:
29206760
9.

Serum levels of interleukin-6 may predict organ dysfunction earlier than SOFA score.

Shimazui T, Matsumura Y, Nakada TA, Oda S.

Acute Med Surg. 2017 Mar 6;4(3):255-261. doi: 10.1002/ams2.263. eCollection 2017 Jul.

10.

[II. What Is the Future of Robot-Assisted Laparoscopic Radical Prostatectomy in Japan ?]

Shimazui T, Yamauchi A, Emura M, Ohtani M.

Gan To Kagaku Ryoho. 2017 Jan;44(1):33-36. Japanese. No abstract available.

PMID:
28676617
11.

Feasibility of classical secondary hormonal therapies prior to docetaxel therapy in Japanese patients with castration-resistant prostate cancer: Multicenter retrospective study.

Kandori S, Yoshino T, Tsutsumi M, Yamauchi A, Ohtani M, Fukuhara Y, Miyanaga N, Miyazaki J, Nishiyama H, Shimazui T.

Prostate Int. 2016 Dec;4(4):140-144. Epub 2016 Sep 20.

12.

The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.

Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Yamauchi A, Shimazui T, Ohtani M.

Jpn J Clin Oncol. 2017 Mar 1;47(3):252-256. doi: 10.1093/jjco/hyw191.

PMID:
27980085
13.

[Combined androgen blockade for prostate cancer].

Shimazui T.

Nihon Rinsho. 2016 May 20;74 Suppl 3:578-83. Japanese. No abstract available.

PMID:
27344797
14.

Economic Burden of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery.

Sakon M, Maehara Y, Kobayashi T, Kobayashi H, Shimazui T, Seo N, Crawford B, Miyoshi I.

Value Health Reg Issues. 2015 May;6:73-79. doi: 10.1016/j.vhri.2015.03.017. Epub 2015 May 16.

PMID:
29698197
15.

Oncological outcomes of metastatic testicular cancers under centralized management through regional medical network.

Inai H, Kawai K, Kojima T, Joraku A, Shimazui T, Yamauchi A, Miyagawa T, Endo T, Fukuhara Y, Miyazaki J, Uchida K, Nishiyama H.

Jpn J Clin Oncol. 2013 Dec;43(12):1249-54. doi: 10.1093/jjco/hyt152. Epub 2013 Oct 6.

PMID:
24101656
16.

Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy.

Ochiai A, Okihara K, Kamoi K, Oikawa T, Shimazui T, Murayama S, Tomita K, Umekawa T, Uemura H, Miki T.

BJU Int. 2013 May;111(6):928-33. doi: 10.1111/j.1464-410X.2012.11683.x. Epub 2013 Jan 18.

17.

Systemic transduction of p16INK4A antitumor peptide inhibits the growth of MBT-2 mouse bladder tumor cell line grafts.

Shimazui T, Yoshikawa K, Miyazaki J, Kojima T, Inai H, Ando S, Uemura H, Uchida K, Nishiyama H.

Int J Oncol. 2013 Feb;42(2):543-8. doi: 10.3892/ijo.2012.1752. Epub 2012 Dec 24.

PMID:
23292502
18.

[Hemorrhagic cystitis].

Shimazui T.

Nihon Rinsho. 2012 Aug;70 Suppl 6:432-7. Japanese. No abstract available.

PMID:
23156545
19.

[Spindle cell sarcoma of the penis: a case report].

Kimura T, Oikawa T, Ikeda A, Yoshino T, Suetomi T, Miyazaki J, Shimazui T, Hashimoto T, Sugita S, Noguchi M, Nishiyama H.

Hinyokika Kiyo. 2012 Jun;58(6):299-305. Japanese.

20.

Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer.

Onozawa M, Miyanaga N, Hinotsu S, Miyazaki J, Oikawa T, Kimura T, Takaoka E, Kawai K, Shimazui T, Sakurai H, Nishiyama H, Akaza H.

Jpn J Clin Oncol. 2012 Sep;42(9):825-30. doi: 10.1093/jjco/hys105. Epub 2012 Jul 10.

PMID:
22782963
21.

[Maximally androgen blockade therapy].

Shimazui T.

Nihon Rinsho. 2011 Jun;69 Suppl 5:477-80. Japanese. No abstract available.

PMID:
22208027
22.

A new molecular targeted therapeutic approach for renal cell carcinoma with a p16 functional peptide using a novel transporter system.

Zennami K, Yoshikawa K, Kondo E, Nakamura K, Upsilonamada Y, De Velasco MA, Tanaka M, Uemura H, Shimazui T, Akaza H, Saga S, Ueda R, Honda N.

Oncol Rep. 2011 Aug;26(2):327-33. doi: 10.3892/or.2011.1290. Epub 2011 Apr 29.

PMID:
21567093
23.

The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands.

Miyazaki J, Kawai K, Kojima T, Oikawa T, Joraku A, Shimazui T, Nakaya A, Yano I, Nakamura T, Harashima H, Akaza H.

BJU Int. 2011 Nov;108(9):1520-6. doi: 10.1111/j.1464-410X.2010.10056.x. Epub 2011 Feb 11.

24.

A case of metastatic testicular cancer complicated by pulmonary hemorrhage due to choriocarcinoma syndrome.

Kandori S, Kawai K, Fukuhara Y, Joraku A, Miyanaga N, Shimazui T, Akaza H.

Int J Clin Oncol. 2010 Dec;15(6):611-4. doi: 10.1007/s10147-010-0092-3. Epub 2010 Jun 11.

PMID:
20544252
25.

Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract: a single institutional retrospective long-term follow-up study.

Takaoka E, Hinotsu S, Joraku A, Oikawa T, Sekido N, Miyanaga N, Kawai K, Shimazui T, Akaza H.

Int J Urol. 2010 Jul;17(7):623-8. doi: 10.1111/j.1442-2042.2010.02539.x. Epub 2010 Apr 19.

26.

FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma.

Kojima T, Shimazui T, Horie R, Hinotsu S, Oikawa T, Kawai K, Suzuki H, Meno K, Akaza H, Uchida K.

Genes Chromosomes Cancer. 2010 Apr;49(4):379-89. doi: 10.1002/gcc.20750.

PMID:
20095040
27.

Successful management by provocative angiography and endovascular stent of Ureteroarterial fistula in a patient with a long-term indwelling ureteral stent.

Yamasaki K, Omori K, Takaoka E, Sekido N, Shigai M, Mori K, Minami M, Watanabe Y, Shimazui T, Akaza H.

Jpn J Clin Oncol. 2010 Mar;40(3):267-70. doi: 10.1093/jjco/hyp154. Epub 2009 Dec 9.

PMID:
20007190
28.

Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: results from a multicenter, randomized, open-label study.

Sakon M, Kobayashi T, Shimazui T.

Thromb Res. 2010 Mar;125(3):e65-70. doi: 10.1016/j.thromres.2009.09.009. Epub 2009 Nov 17.

PMID:
19919878
29.

Suppression of AhR signaling pathway is associated with the down-regulation of UDP-glucuronosyltransferases during BBN-induced urinary bladder carcinogenesis in mice.

Iida K, Mimura J, Itoh K, Ohyama C, Fujii-Kuriyama Y, Shimazui T, Akaza H, Yamamoto M.

J Biochem. 2010 Mar;147(3):353-60. doi: 10.1093/jb/mvp169. Epub 2009 Oct 29.

PMID:
19880377
30.

Low expression of microphthalmia-associated transcription factor, a potential molecular target for interferon-alpha susceptibility, is associated with metastasis in renal cell carcinoma.

Shimazui T, Kojima T, Yoshikawa K, Ami Y, Oikawa T, Uchida K, Akaza H.

Cancer Sci. 2009 Sep;100(9):1714-8. doi: 10.1111/j.1349-7006.2009.01216.x. Epub 2009 May 12.

31.

Extremely acute exacerbation of interstitial pneumonia after interferon-alpha treatment for metastatic renal cell carcinoma.

Ando S, Kawai K, Kuriyagawa K, Sekido N, Miyanaga N, Shimazui T, Akaza H.

Int J Clin Oncol. 2009 Apr;14(2):171-3. doi: 10.1007/s10147-008-0817-8. Epub 2009 Apr 24.

PMID:
19390951
32.

Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.

Kojima T, Shimazui T, Hinotsu S, Joraku A, Oikawa T, Kawai K, Horie R, Suzuki H, Nagashima R, Yoshikawa K, Michiue T, Asashima M, Akaza H, Uchida K.

Oncogene. 2009 Jan 15;28(2):297-305. doi: 10.1038/onc.2008.391. Epub 2008 Oct 20.

PMID:
18931698
33.

Cavernous hemangioma mimicking a cystic renal cell carcinoma.

Takaoka E, Sekido N, Naoi M, Matsueda K, Kawai K, Shimazui T, Akaza H.

Int J Clin Oncol. 2008 Apr;13(2):166-8. doi: 10.1007/s10147-007-0700-z. Epub 2008 May 8.

PMID:
18463963
34.

Clinical practice manual for late-onset hypogonadism syndrome.

Namiki M, Akaza H, Shimazui T, Ito N, Iwamoto T, Baba K, Kumano H, Koh E, Tsujimura A, Matsumiya K, Horie S, Maruyama O, Marumo K, Yanase T, Kumamoto Y; Working Committee on Clinical Practice Guidelines for Late-onset Hypogonadism; Japanese Urological Association/Japanese Society for Study of Aging Male.

Int J Urol. 2008 May;15(5):377-88. doi: 10.1111/j.1442-2042.2008.02010.x. No abstract available.

35.

Negative impact of metabolic syndrome on the responsiveness to sildenafil in Japanese men.

Suetomi T, Kawai K, Hinotsu S, Joraku A, Oikawa T, Sekido N, Miyanaga N, Shimazui T, Akaza H.

J Sex Med. 2008 Jun;5(6):1443-50. doi: 10.1111/j.1743-6109.2007.00747.x. Epub 2008 Jan 18.

PMID:
18208503
36.

Background Variables for the Patients with Invasive Bladder Cancer Suitable for Bladder-preserving Therapy.

Miyanaga N, Akaza H, Hinotsu S, Joraku A, Oikawa T, Sekido N, Kawai K, Shimazui T.

Jpn J Clin Oncol. 2007 Nov;37(11):852-7. Epub 2007 Oct 26.

PMID:
17965422
37.

Three-weekly docetaxel with prednisone is feasible for Japanese patients with hormone-refractory prostate cancer: a retrospective comparative study with weekly docetaxel alone.

Shimazui T, Kawai K, Miyanaga N, Kojima T, Sekido N, Hinotsu S, Oikawa T, Joraku A, Akaza H.

Jpn J Clin Oncol. 2007 Aug;37(8):603-8. Epub 2007 Aug 2.

PMID:
17673473
38.

Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis.

Iida K, Itoh K, Maher JM, Kumagai Y, Oyasu R, Mori Y, Shimazui T, Akaza H, Yamamoto M.

Carcinogenesis. 2007 Nov;28(11):2398-403. Epub 2007 Jun 29.

PMID:
17602169
39.

Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles.

Tamura K, Furihata M, Tsunoda T, Ashida S, Takata R, Obara W, Yoshioka H, Daigo Y, Nasu Y, Kumon H, Konaka H, Namiki M, Tozawa K, Kohri K, Tanji N, Yokoyama M, Shimazui T, Akaza H, Mizutani Y, Miki T, Fujioka T, Shuin T, Nakamura Y, Nakagawa H.

Cancer Res. 2007 Jun 1;67(11):5117-25.

40.

Does tumor size or microvascular invasion affect prognosis in patients with renal cell carcinoma?

Miyagawa T, Shimazui T, Hinotsu S, Oikawa T, Sekido N, Miyanaga N, Kawai K, Akaza H.

Jpn J Clin Oncol. 2007 Mar;37(3):197-200. Epub 2007 Mar 14.

PMID:
17360737
41.

Prediction of in vitro response to interferon-alpha in renal cell carcinoma cell lines.

Shimazui T, Ami Y, Yoshikawa K, Uchida K, Kojima T, Oikawa T, Nakamura K, Honda N, Hinotsu S, Miyazaki J, Kunita N, Akaza H.

Cancer Sci. 2007 Apr;98(4):529-34. Epub 2007 Jan 31.

42.

Splenogonadal fusion: case report and review of published works.

Ando S, Shimazui T, Hattori K, Yamamoto T, Kuriyagawa K, Akaza H.

Int J Urol. 2006 Dec;13(12):1539-41.

43.

Tissue elasticity imaging for diagnosis of prostate cancer: a preliminary report.

Miyanaga N, Akaza H, Yamakawa M, Oikawa T, Sekido N, Hinotsu S, Kawai K, Shimazui T, Shiina T.

Int J Urol. 2006 Dec;13(12):1514-8.

44.

Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.

Kawai K, Hinotsu S, Oikawa T, Sekido N, Hattori K, Miyanaga N, Hasegawa Y, Kojima H, Shimazui T, Akaza H.

Jpn J Clin Oncol. 2006 Nov;36(11):723-30. Epub 2006 Nov 2.

PMID:
17082218
45.

How many uncomplicated male and female overactive bladder patients reveal detrusor overactivity during urodynamic study?

Sekido N, Hinotsu S, Kawai K, Shimazui T, Akaza H.

Int J Urol. 2006 Oct;13(10):1276-9.

46.
47.

[A case of Kallmann syndrome: usefulness of the aging male's symptoms rating scale for assessment of subjective symptoms].

Suetomi T, Inai H, Manabe F, Shimazui T, Akaza H.

Hinyokika Kiyo. 2006 Aug;52(8):661-5. Japanese.

48.

A case of metastatic testicular cancer complicated by tumour lysis syndrome and choriocarcinoma syndrome.

Kawai K, Takaoka E, Naoi M, Mori K, Minami M, Shimazui T, Akaza H.

Jpn J Clin Oncol. 2006 Oct;36(10):665-7. Epub 2006 Aug 24.

PMID:
16935862
49.

[Bilateral uretero-common iliac arterial fistula with long term uretelal stent: a case report].

Ando S, Hattori K, Endo T, Inai H, Matsueda K, Imazuru T, Sakakibara Y, Kawai K, Shimazui T, Akaza H.

Nihon Hinyokika Gakkai Zasshi. 2006 Jul;97(5):752-6. Review. Japanese.

50.

Completion and toxicity of induction chemotherapy for metastatic testicular cancer: an updated evaluation of Japanese patients.

Kawai K, Ando S, Hinotsu S, Oikawa T, Sekido N, Miyanaga N, Shimazui T, Akaza H.

Jpn J Clin Oncol. 2006 Jul;36(7):425-31. Epub 2006 Jun 20.

PMID:
16790450

Supplemental Content

Loading ...
Support Center